Our Services
Medical Information
Helpful Resources
Published on: 4/29/2026
PRP therapy is often billed as “FDA approved” even though only the blood-processing devices receive clearance and the actual treatments fall under a practice of medicine exemption—creating mixed clinical evidence and marketing confusion.
To make informed decisions about safety, effectiveness and cost you need to define your goals, verify provider credentials and understand the protocols used. See below for the full breakdown of all these considerations and medically approved next steps.
Platelet-rich plasma (PRP) therapy has become a buzzword in orthopedics, dermatology, sports medicine and even cosmetic procedures. If you've been researching treatments for joint pain, hair loss or skin rejuvenation, you've probably come across claims like "FDA-approved PRP." Yet when you dig deeper, the regulatory picture is anything but clear. Here's a breakdown of why FDA approval for PRP is confusing, what's actually approved (and what isn't), and medically sound next steps you can take.
PRP stands for platelet-rich plasma, a concentrate of your own blood components:
How it works:
Proposed benefits:
While preliminary studies are promising in some areas (e.g., mild to moderate osteoarthritis, tendon injuries), the evidence is mixed and protocol standards vary widely.
One major source of confusion is that the FDA does not "approve" PRP as a drug. Instead:
Key points on FDA regulation:
Device vs. Treatment
Practice of Medicine Exemption
Mixed Clinical Evidence
Marketing vs. Regulation
Safety Profile: PRP is generally safe when prepared and administered properly by a trained professional, since you're using your own blood.
Effectiveness: Best evidence exists for certain orthopedic uses (e.g., mild knee osteoarthritis, lateral epicondylitis). Results in other areas (hair growth, skin rejuvenation) are promising but less conclusive.
Standardization Issues: Variability in PRP preparation leads to variable results. Ask your provider about:
Cost and Coverage: Most insurers consider PRP experimental and do not cover it. Out-of-pocket costs can range from several hundred to over a thousand dollars per session.
If you're considering PRP, here's a roadmap to make informed decisions:
Discuss Your Goals and Expectations
Verify Your Provider's Credentials
Understand the Protocol
Review the Evidence
Consider a Symptom Check
If you're unsure whether PRP is right for you—or if you need to explore other medical options first—start by checking your symptoms with a Medically approved LLM Symptom Checker Chat Bot. This free tool can help you understand your condition better and determine whether PRP is even appropriate for your specific situation before investing time and money in consultations.
Insurance and Cost
PRP can be part of a broader treatment plan, but it should not delay diagnosis or management of serious conditions. Always speak to a qualified healthcare professional if you have:
If you're experiencing life-threatening or serious symptoms, call emergency services or go to your nearest emergency department immediately.
The confusion around "FDA approval for PRP" stems from mixed messaging between device clearances, off-label medical use and marketing claims. While PRP shows promise—especially in certain orthopedic indications—it's not a one-size-fits-all, FDA-endorsed cure. Before proceeding:
By arming yourself with credible information and professional guidance, you can make the best decision about whether PRP is right for you.
(References)
* Mautner K, Mazzola K, Boden S, Dhillon MS, Gillogly SD, Marx RE. The regulatory landscape of platelet-rich plasma products in the United States: an update. Am J Sports Med. 2017 Jul;45(9):2191-2195. doi: 10.1177/0363546517704515. PMID: 28448096.
* Marx RE. Platelet-Rich Plasma in Sports Medicine: A Regulatory Minefield. Arthroscopy. 2018 Jan;34(1):2-5. doi: 10.1016/j.arthro.2017.09.022. PMID: 29277490.
* Kassir R, Kroumpouzos G, Gold MH. Platelet-Rich Plasma in Dermatology: A Review of the Current Regulatory Framework and Future Perspectives. J Cutan Med Surg. 2020 Jan/Feb;24(1):64-71. doi: 10.1177/1203475419889415. PMID: 31713502.
* Dhond A, Mazzola K, Gopinath A, Mautner K. Navigating the Regulatory Landscape of Regenerative Medicine: Focus on Platelet-Rich Plasma. J Clin Aesthet Dermatol. 2021 Jul;14(7):E64-E68. PMID: 34336214; PMCID: PMC8309139.
* Delong J, Miller J, Delong T, Delong A. Platelet-rich plasma for musculoskeletal conditions: an update on current evidence and regulatory status. Curr Rev Musculoskelet Med. 2023 Aug;16(8):378-386. doi: 10.1007/s12178-023-09855-y. Epub 2023 Jul 4. PMID: 37400788; PMCID: PMC10372559.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.